Negative Regulation of Hepatitis C Virus Specific Immunity Is Highly Heterogeneous and Modulated by Pegylated Interferon-Alpha/Ribavirin Therapy

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Claassen, Mark A A ^a   de Knegt, Robert J ^a   Turgut, Duygu ^a   Groothuismink, Zwier M A ^a   Janssen, Harry L A ^a   Boonstra, André ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; PEGINTERFERON ALPHA2B; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA;

ADULT; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN DEPLETION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTIVIRAL AGENTS; CELL PROLIFERATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, CELLULAR; INTERFERON-ALPHA; INTERLEUKIN-10; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84869070326     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049389     Document Type: Article

References (36)

1. Dustin LB, Rice CM, (2007) Flying under the radar: the immunobiology of hepatitis C. Annu Rev Immunol. 25: 71-99.
2. Rehermann B, (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754.
3. Boonstra A, Woltman AM, Janssen HL, (2008) Immunology of hepatitis B and hepatitis C virus infections. Best Pract Res Clin Gastroenterol 22: 1049-1061.
4. Belkaid Y, (2007) Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 7: 875-888.
5. Raziorrouh B, Ulsenheimer A, Schraut W, Heeg M, Kurktschiev P, et al. (2011) Inhibitory Molecules That Regulate Expansion and Restoration of HCV-Specific CD4(+) T Cells in Patients With Chronic Infection. Gastroenterology.
6. Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, et al. (2007) Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 47: 316-324.
7. Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A, (2010) Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 52: 315-321.
8. Sturm N, Thelu MA, Camous X, Dimitrov G, Ramzan M, et al. (2010) Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. J Hepatol 53: 25-35.
9. Claassen MA, de Knegt RJ, Janssen HL, Boonstra A, (2011) Retention of CD4+CD25+FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans. J Virol 85: 5323-5330.
10. Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, et al. (2005) T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79: 7860-7867.
11. Bolacchi F, Sinistro A, Ciaprini C, Demin F, Capozzi M, et al. (2006) Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin Exp Immunol 144: 188-196.
12. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, et al. (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40: 1062-1071.
13. Manigold T, Shin EC, Mizukoshi E, Mihalik K, Murthy KK, et al. (2006) Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C. Blood. 107: 4424-4432.
14. Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, et al. (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79: 7852-7859.
15. Brady MT, MacDonald AJ, Rowan AG, Mills KH, (2003) Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. Eur J Immunol 33: 3448-3457.
16. Rigopoulou EI, Abbott WG, Haigh P, Naoumov NV, (2005) Blocking of interleukin-10 receptor-a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin Immunol 117: 57-64.
17. Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, et al. (2007) Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 81: 5882-5892.
18. Kaplan DE, Ikeda F, Li Y, Nakamoto N, Ganesan S, et al. (2008) Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J Hepatol 48: 903-913.
19. Rowan AG, Fletcher JM, Ryan EJ, Moran B, Hegarty JE, et al. (2008) Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol 181: 4485-4494.
20. Abel M, Sene D, Pol S, Bourliere M, Poynard T, et al. (2006) Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection. Hepatology 44: 1607-1616.
21. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, et al. (2004) Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113: 963-972.
22. Liu BS, Groothuismink ZM, Janssen HL, Boonstra A, (2011) Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections. J Leukoc Biol 89: 981-988.
23. Klenerman P, Barnes E (2007) Immune responses against the hepatitis C virus and the outcome of therapy. In: Jirillo E, editor. Hepatitis C virus disease. New York: Springer. 71-86.
24. Suneetha PV, Schlaphoff V, Wang C, Stegmann KA, Fytili P, et al. (2009) Effect of peptide pools on effector functions of antigen-specific CD8+ T cells. J Immunol Methods 342: 33-48.
25. Stoop JN, Claassen MA, Woltman AM, Binda RS, Kuipers EJ, et al. (2008) Intrahepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients. Clin Immunol 129: 419-427.
26. Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, et al. (2010) Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 6: e1000947.
27. Schlaphoff V, Lunemann S, Suneetha PV, Jaroszewicz J, Grabowski J, et al. (2011) Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 7: e1002045.
28. de Lujan Alvarez M, Ronco MT, Ochoa JE, Monti JA, Carnovale CE, et al. (2004) Interferon alpha-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor beta(1). Hepatology 40: 394-402.
29. Quiroga AD, de Lujan Alvarez M, Parody JP, Ronco MT, Carnovale CE, et al. (2009) Interferon-alpha2b (IFN-alpha2b)-induced apoptosis is mediated by p38 MAPK in hepatocytes from rat preneoplastic liver via activation of NADPH oxidase. Growth Factors 27: 214-227.
30. Birerdinc A, Afendy A, Stepanova M, Younossi I, Manyam G, et al. (2010) Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C. J Viral Hepat. 17: 730-736.
31. Lin W, Tsai WL, Shao RX, Wu G, Peng LF, et al. (2010) Hepatitis C virus regulates transforming growth factor beta1 production through the generation of reactive oxygen species in a nuclear factor kappaB-dependent manner. Gastroenterology 138: 2509-2518, 2518 e2501.
32. Camma C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, et al. (2004) Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. Hepatology 39: 333-342.
33. Grungreiff K, Reinhold D, Ansorge S, (1999) Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Cytokine 11: 1076-1080.
34. Marek B, Kajdaniuk D, Mazurek U, Janczewska-Kazek E, Kos-Kudla B, et al. (2005) TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy. J Clin Pharm Ther 30: 271-277.
35. Burton JR, Klarquist J, Im K, Smyk-Pearson S, Golden-Mason L, et al. (2008) Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy. J Hepatol 49: 329-338.
36. Schulze Zur Wiesch J, Ciuffreda D, Lewis-Ximenez L, Kasprowicz V, Nolan BE, et al. (2012) Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. J Exp Med 209: 61-75.